Atopic dermatitis (AD) is a common skin condition and is undertreated in children under 2 years, whom there are no specific guidelines for. We sought to understand barriers to AD treatment and primary care pediatricians’ (PCPs) suggested solutions. We conducted semi-structured focus groups (n = 5) with PCPs (n = 17) on how the undertreatment of AD can be addressed. Data were analyzed using an inductive qualitative approach. Participants noted that the perceived undertreatment of AD in children under 2 years could be explained by topical corticosteroid (TCS) use hesitancy, lack of caregiver adherence to PCP recommendations, and under-documentation of AD in the electronic medical record (EMR). Proposed suggestions for improving AD management included caregiver and PCP education on TCS safety; stepwise management guidelines for this age group; and EMR aids to help document and manage AD. Research is warranted to create and disseminate clinician-friendly AD management guidelines for this age group.
ShawTECurrieGPKoudelkaCWSimpsonEL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011;131(1):67-73.
2.
KayJGawkrodgerDJMortimerMJJaronAG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol. 1994;30(1):35-39.
3.
SaavedraJMBoguniewiczMChamlinS, et al. Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United States. J Pediatr. 2013;163(6):1747-1753.
4.
PowellKLe RouxEBanksJPRiddMJ. Developing a written action plan for children with eczema: a qualitative study. Br J Gen Pract. 2018;68(667):e81-e89.
5.
Le RouxEPowellKBanksJPRiddMJ. GPs’ experiences of diagnosing and managing childhood eczema: a qualitative study in primary care. Br J Gen Pract. 2018;68(667):e73-e80.
6.
PowellKLe RouxEBanksJRiddMJ. GP and parent dissonance about the assessment and treatment of childhood eczema in primary care: a qualitative study. BMJ Open. 2018;8(2):e019633.
7.
SanterMBurgessHYardleyL, et al. Managing childhood eczema: qualitative study exploring carers’ experiences of barriers and facilitators to treatment adherence. J Adv Nurs. 2013;69(11):2493-2501.
8.
El HachemMGesualdoFRicciG, et al. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey. Ital J Pediatr. 2017;43(1):22.
9.
SmithSDHongEFearnsSBlaszczynskiAFischerG. Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Australas J Dermatol. 2010;51(3):168-174. doi:10.1111/j.1440-0960.2010.00636.x.
10.
PallerASTomWLCallRS, et al. 033 A novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase inhibitor, Crisaborole Topical Ointment, 2%, in two phase 3 studies in children and adults with mild to moderate atopic dermatitis. J Invest Dermatol. 2016;136(9):S166. doi:10.1016/j.jid.2016.06.050.
11.
EichenfieldLFBeckL. Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for the treatment of atopic dermatitis. J Allergy Clin Immunol. 2003;111(5):1153-1168. doi:10.1067/mai.2003.1492.
EichenfieldLFBoguniewiczMSimpsonEL, et al. Translating atopic dermatitis management guidelines into practice for primary care providers. Pediatrics. 2015;136(3):554-565.
14.
SchneiderLTillesSLioP, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2):295-299.e27. doi:10.1016/j.jaci.2012.12.672.
15.
EichenfieldLFTomWLChamlinSL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-351.
16.
EichenfieldLFTomWLBergerTG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116-132.
17.
SidburyRDavisDMCohenDE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327-349.
18.
SidburyRTomWLBergmanJN, et al. Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014;71(6):1218-1233.
19.
BoguniewiczMFonacierLGuttman-YasskyEOngPYSilverbergJFarrarJR. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120(1):10-22.e2.
20.
FishbeinABHamidehNLorJ, et al. Management of atopic dermatitis in children younger than two years of age by community pediatricians: a survey and chart review. J Pediatr. 2020;221:138-144.
21.
CamposALBde AraújoFMSantosMALDSantosAASDPiresCAA. Impact of atopic dermatitis on the quality of life of pediatric patients and their guardians. Rev Paul Pediatr. 2017;35(1):5-10.
22.
AngelhoffCAskentegHWiknerUEdéll-GustafssonU. “To cope with everyday life, I need to sleep”—a phenomenographic study exploring sleep loss in parents of children with atopic dermatitis. J Pediatr Nurs. 2018;43:e59-e65.
23.
SimpsonELBerryTMBrownPAHanifinJM. A pilot study of emollient therapy for the primary prevention of atopic dermatitis. J Am Acad Dermatol. 2010;63(4):587-593.
24.
LeungDYMGuttman-YasskyE. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014;134(4):769-779.
25.
LeBaillySArizaABayldonBBinnsHJ. The origin and evolution of a regional pediatric practice-based research network: practical and methodological lessons from the pediatric practice research group. Curr Probl Pediatr Adolesc Health Care. 2003;33(4):124-134. doi:10.1067/mps.2003.13.
National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007;120(suppl 5):S94-S138.
28.
FishbeinABMuellerKLorJSmithPPallerASKaatA. Systematic review and meta-analysis comparing topical corticosteroids with vehicle/moisturizer in childhood atopic dermatitis. J Pediatr Nurs. 2019;47:36-43.
29.
FishbeinABSilverbergJIWilsonEJOngPY. Update on atopic dermatitis: diagnosis, severity assessment, and treatment selection. J Allergy Clin Immunol Pract. 2020;8(1):91-101.
30.
LiAWYinESAntayaRJ. Topical corticosteroid phobia in atopic dermatitis: a systematic review. JAMA Dermatol. 2017;153(10):1036-1042.
31.
YumHYKimHHKimHJ, et al. Current management of moderate-to-severe atopic dermatitis: a survey of allergists, pediatric allergists and dermatologists in Korea. Allergy Asthma Immunol Res. 2018;10(3):253-259.
